Craniomaxillofacial Devices Industry Overview
The global craniomaxillofacial devices market size was valued at USD 1.5 billion in 2021 and is projected to witness a compound annual growth rate (CAGR) of 9.4% from 2022 to 2030.
The shift in preference towards minimally invasive surgeries owing to the availability of technologically advanced products is one of the key factors expected to support market growth. For instance, leading player Zimmer Biomet offers ROSA ONE Brain, a robotic platform that aids in performing complex neurosurgical procedures to be performed minimally invasive, often without needing to shave the entire head. Thus, companies coming up with innovative devices are expected to drive the market. The COVID-19 outbreak led to restrictions on many elective procedures as the healthcare facilities were burdened with COVID-19-affected patients. The American Society of Plastic Surgeons reported that reconstructive surgical procedures which also included Maxillofacial Surgery witnessed a decrease.
Gather more insights about the market drivers, restrains and growth of the Global Craniomaxillofacial Devices Market
The rise in the number of facial and head injuries caused due to sports-related injuries is also expected to boost demand for craniomaxillofacial devices. According to the Centers for Disease Control and Prevention (CDC), an estimated 1.7 to 3.8 million traumatic brain injuries are reported each year in the U.S., of these, 10% arise due to sports and recreational activities. Furthermore, the U.S. Consumer Product Safety Commission (CPSC) data stated that, in 2018, 454,407 sports-related head injuries were treated at the U.S. hospital emergency rooms. This highlights the high growth prospects that lie ahead for craniomaxillofacial device manufacturers in the country.
The U.S.Temporomandibular Joint Replacement product type segment is expected to witness a compound annual growth rate of 10.1% during the forecast period.
Rising incidents of road accidents are also expected to increase the demand for craniomaxillofacial devices. According to Columbia University (Department of Neurology), motor vehicle accidents are one of the most common causes of Traumatic Brain Injury (TBI) among children and adults in the U.S. The rise in the number of road accidents across the globe is expected to boost demand for craniomaxillofacial devices, especially in developing countries.
According to the American Society of Plastic Surgeons in 2020 around 256,085 maxillofacial reconstructive surgery procedures were carried out in the U.S. The procedure is also among the top five most carried out plastic surgery procedures in the country. As per John Hopkins Medicine, around more than 3.5 million injuries from sports are reported each year in the U.S and almost one-third of all injuries incurred in childhood are sports-related injuries
The COVID-19 pandemic significantly affected the craniomaxillofacial devices market. It had led to the cancellation and rescheduling of surgical procedures at a global level. For surgeons working in the craniomaxillofacial (CMF) field, surgical procedures are limited to urgent or emergent cases. Medartis AG, a key manufacturer of craniomaxillofacial implants reported that the company’s products witnessed a decline as elective procedures were halted resulting in production stoppages and supply chain bottlenecks.
Renishaw Plc, a major player in CMF implants in Europe stated in its annual report that its medical dental line had lower sales than in 2020, as demand for additively manufactured CMF implants and dental structures was affected by the pandemic due to the reduction in non-essential operations.
However, the market has witnessed a positive recovery in 2021 and many competitors in the market experienced growth in sales of CMF products as medical surgeries resumed with strict Covid-19 protocols in place.
Browse through Grand View Research's Medical Devices Industry Related Reports
- Bone Grafts And Substitutes Market - The global bone grafts and substitutes market size was valued at USD 2.91 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2030. One of the key factors fueling the growth of the market is the rising incidence of bone and joint disorders.
- Cranial Fixation and Stabilization Devices Market - The global cranial fixation and stabilization devices market size was valued at USD 1.69 billion in 2017. It is expected to witness a CAGR of 5.6% during the forecast period. Surging demand for minimally invasive neurosurgeries is estimated to fuel the demand for these devices in the coming years.
Market Share Insights
December 2021: DePuy Synthes acquired the Israeli company, OrthoSpin, Ltd. OrthoSpin develops and manufactures a patented automated strut system, which will be used in conjunction with DePuy Synthes MAXFRAME Multi-Axial Correction System, an external ring fixation system.
November 2021: DePuy Synthes launched the UNIUM System as a next-generation power tools system for trauma and small bone procedures. This system can also be used across, sports medicine, spine and thorax procedures
Key Companies profiled:
Some prominent players in the global Craniomaxillofacial Devices market include
- DePuy Synthes (J&J),
- Stryker
- Medtronic
- Braun Melsungen AG
- Renishaw Plc
- Medartis AG
- KLS Martin Group
- Xilloc Medical B. V
- Synimed
- Zimmer-Biomet
Order a free sample PDF of the Craniomaxillofacial Devices Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment